A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

Clinical trial NCT06547840 · RECRUITING

Trial details

NCT number: NCT06547840
Sponsor: Epsilogen Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Ovarian Cancer Platinum-resistant Ovarian Cancer Triple Negative Breast Cancer (TNBC)Triple -Negative Breast Cancer Endometrial Cancer Advanced Endometrial Cancer

Start date: 2024-09-03
Primary completion: 2026-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.